Higashimurayama, Japan

Takafumi Kunieda

This inventor holds 3 USPTO granted patents. Top assignee: Kowa Company Limited. Active years: 1980-1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takafumi Kunieda. Retrieved from https://idiyas.com/inventor/takafumi-kunieda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1980-1983

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takafumi Kunieda: Innovator in Antibiotic Development

Introduction

Takafumi Kunieda is a notable inventor based in Higashimurayama, Japan. He has made significant contributions to the field of antibiotic research, holding a total of 3 patents. His work focuses on developing novel antibiotics that have the potential to address critical health challenges.

Latest Patents

Among his latest patents, Kunieda has developed biologically pure cultures and novel antibiotics characterized by specific chemical structures. These antibiotics include a moiety selected from a group consisting of hydrogen, --COCH.sub.2 NH.sub.2, --COCH.sub.2 NHCONH.sub.2, and --COCH.sub.2 NHCHO. The processes for their preparation and the biologically pure cultures for use therein are also part of his innovative contributions.

Career Highlights

Kunieda is associated with Kowa Company Limited, where he continues to advance his research in antibiotic development. His work is crucial in the ongoing fight against antibiotic resistance and the search for effective treatments.

Collaborations

He collaborates with esteemed colleagues such as Toshihito Mori and Takeo Deushi, contributing to a dynamic research environment that fosters innovation.

Conclusion

Takafumi Kunieda's work in developing novel antibiotics and biologically pure cultures highlights his commitment to improving healthcare through innovation. His contributions are vital in the ongoing battle against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…